Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding the PTSC Annual SHM held on 1/28/2010

Is there any arguments for share buybacks that should be considered?

YES, against. They would need to buy back 2-300 million shares at least to have any impact whatsoever. And I don't think even that will make any difference. The issue is not the outstanding shares. It is about business ability as demonstrated by income/profit.

For the BOD

DON"T invest OUR money

DISTRIBUTE OUR money to us directly.

I will do my own investing.

Good Luck

(I) C. W.

Share
New Message
Please login to post a reply